Use of administrative claims data for comparative effectiveness research of rheumatoid arthritis treatments

Arthritis Research and Therapy

Volumn 13, Issue 5, 2011, Pages

  Kim, Seo Y ^a   Solomon, Daniel H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ADALIMUMAB; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GLUCOCORTICOID; INFLIXIMAB; RITUXIMAB; ANTIRHEUMATIC AGENT;

ALGORITHM; BIOLOGICAL THERAPY; CLAIMS BASED ALGORITHM; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; DRUG SAFETY; EDITORIAL; FOLLOW UP; HEALTH CARE COST; HUMAN; LONG TERM CARE; MEDICAL INFORMATION SYSTEM; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; TREATMENT DURATION; FEMALE; GOVERNMENT; INSURANCE; MALE; NOTE; STANDARD;

ALGORITHMS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; MALE; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 80053586739     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3472     Document Type: Editorial

References (7)

1. Curtis JR, Baddley JW, Yang S, Patkar N, Chen L, Delzell E, Mikuls TR, Saag KG, Singh J, Safford M, Cannon GW. Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis. Arthritis Res Ther 2011, 13:R155. 10.1186/ar3471, 21933396.
2. Institute of Medicine Initial National Priorities for Comparative Effectiveness Research 2009, Washington, DC: Institute of Medicine, Institute of Medicine.
3. Curtis JR, Jain A, Askling J, Bridges SL, Carmona L, Dixon W, Finckh A, Hyrich K, Greenberg JD, Kremer J, Listing J, Michaud K, Mikuls T, Shadick N, Solomon DH, Weinblatt ME, Wolfe F, Zink A. A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries. Semin Arthritis Rheum 2010, 40:2-14. 10.1016/j.semarthrit.2010.03.003, 2958101, 20674669.
4. Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol 2005, 58:323-327. 10.1016/j.jclinepi.2004.10.012, 15862718.
5. Kim S, Servi A, Polinski J, Mogun H, Weinblatt M, Katz J, Solomon DH. Validation of rheumatoid arthritis diagnoses in health care utilization data. Arthritis Res Ther 2011, 13:R32. 10.1186/ar3260, 21345216.
6. Solomon DH, Avorn J, Katz JN, Weinblatt ME, Setoguchi S, Levin R, Schneeweiss S. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum 2006, 54:3790-3798. 10.1002/art.22255, 17136752.
7. Solomon D, Massarotti E, Garg R, Liu J, Canning C, Schneeweiss S. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. JAMA 2011, 305:2525-2531. 10.1001/jama.2011.878, 21693740.